Compugen Ltd.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles about it in the 4Search index. Click a dot on the chart for the event and the news of that day.
Key statistics
Against its peers
Compare in full ›| CGEN.TA | CRVS | BINV.ST | CHRS | 2157.HK | PYXS | |
|---|---|---|---|---|---|---|
| Market cap | 601.43M | 815.69M | 137.53M | 57.15M | 4.35B | 216.49M |
| P/E (TTM) | 5.3 | — | — | — | 14.2 | — |
| Forward P/E | — | -8.8 | -0.5 | -0.6 | — | -2.2 |
| Price/book | 7.2 | 3.9 | 0.7 | 2.3 | 2.6 | 3.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +24.08% | +16.80% | −91.08% | −66.64% | −56.16% | −64.85% |
| Today | −2.31% | −3.40% | −3.69% | −4.47% | −4.55% | +7.74% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All CGEN.TA news ›Compugen: COM701 Data On Track And Continued Bispecific Rilvegostomig Development
Compugen is rated a Buy, as COM701 targets Q1 2027 results and $117.5 million supporting operations into 2029. Click to read more about CGEN. - Compugen Ltd. maintains a "Buy" rating, driven by advancing clinical programs and strong…
Compugen Q3 2026: Revenue Nearly 3x Estimates With Binary Catalyst Ahead
As seen on the 24/7 Wall St. homepage on November 9, 2026. A $117.5 million cash position funds operations into 2029, after Gilead upfront and IND milestone recognition more than doubled revenue year over year and came in 291.9% above…
Compugen Non-GAAP EPS of -$0.06 beats by $0.03, revenue of $3.8M beats by $2.83M
Compugen Q3 earnings beat estimates on EPS and revenue, with $117.5M in cash funding operations into 2029. - Compugen press release (CGEN): Q3 Non-GAAP EPS of -$0.06 beats by $0.03. - Revenue of $3.8M (+100.0% Y/Y) beats by $2.83M. - Cash:…
Compugen anticipates COM701 MAIA-ovarian data by end of Q1 2027 while funding plans into 2029
Compugen Q3 2026 earnings highlights MAIA-Ovarian enrollment, 2027 catalysts, UnigenX expansion, and cash runway into 2029. Earnings Call Insights: Compugen (CGEN) Q3 2026 What are Compugen’s key upcoming clinical catalysts? How could…
Compugen (CGEN): Pipeline Inflection Points, Deferred Revenue Depletion, and 2027 Binary Catalysts
Compugen Ltd. (Nasdaq: CGEN), an Israel-based clinical-stage immunotherapy company, reported third-quarter 2026 results on November 9, 2026, delivering an earnings-per-share... The post Compugen (CGEN): Pipeline Inflection Points, Deferred…
Transcript : Compugen Ltd. - Special Call
Presenter SpeechDanya Ben-Hail Hello, everyone. Welcome to Jones fireside chat with Dr. Eran Ophir, President and CEO of Compugen. I am Danya Ben Hail, an analyst at Jones Research. Compugen was... Transcript : Compugen Ltd. - Special Call…
Compugen Ltd. Appoints Michele Holcomb to Its Board of Directors, Effective February 11, 2026
Compugen Ltd. announced the appointment of Michele Holcomb, Ph.D., as a new independent director, effective February 11, 2026. Dr. Holcomb is a strategic leader with more than 30 years of healthcare... announced the appointment of Michele…
Compugen (NASDAQ:CGEN) Issues Earnings Results
Posted by Mitch Edgeman on Nov 9th, 2026 CGEN stock opened at $1.96 on Monday. Compugen has a fifty-two week low of $1.43 and a fifty-two week high of $3.23. The company has a market capitalization of $185.32 million, a price-to-earnings…
Compugen to Release Third Quarter 2026 Results on Monday, November 9, 2026
/PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery... HOLON, Israel, Oct. 26, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN)…
Compugen to Participate in November Investor Conferences
/PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery powered... HOLON, Israel, Nov. 3, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN)…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com12
- seekingalpha.com4
- prnewswire.com3
- 247wallst.com1
- defenseworld.net1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 24 articles, not a forecast.